Practice

Commentary: Managing clinicians’ assessment

BMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b5177 (Published 10 December 2009) Cite this as: BMJ 2009;339:b5177
  1. Reinhard Reuß, physician 1,
  2. Michael Bolz, senior physician 2,
  3. Uwe K Zettl, professor1
  1. 1Department of Neurology, University of Rostock, 18147 Rostock, Germany
  2. 2Department of Gynaecology, University of Rostock
  1. Correspondence to: R Reuß reinhard.reuss{at}neuro.med.uni-giessen.de

    When Mrs G presented to the emergency room, clinical examination with transverse spinal cord syndrome, magnetic resonance imaging, and her complete clinical remission after plasmapheresis as well as lack of response to treatment pointed to longitudinally extensive transverse myelitis, representing an inaugural or limited form of neuromyelitis optica. The diagnosis was confirmed by detection of anti-aquaporin 4 (AQP4) antibodies.

    In the rapid responses Mike Boggild states that a variety of other autoantibodies are often seen within the spectrum of neuromyelitis optica disorders.1 Conversely, several cases of pregnancy related …

    View Full Text

    Sign in

    Log in through your institution

    Subscribe